Wells Fargo’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,750
| Closed | -$5K | – | 7738 |
|
|
2023
Q2 | $5K | Sell |
23,750
-5,990
| -20% | -$1.04K | ﹤0.01% | 6080 |
|
|
2023
Q1 | $4.76K | Sell |
29,740
-85,470
| -74% | -$38K | ﹤0.01% | 6069 |
|
|
2022
Q4 | $63.9K | Sell |
115,210
-235,731
| -67% | -$201K | ﹤0.01% | 4752 |
|
|
2022
Q3 | $418K | Sell |
350,941
-105,854
| -23% | -$114K | ﹤0.01% | 3811 |
|
|
2022
Q2 | $289K | Sell |
456,795
-448,392
| -50% | -$344K | ﹤0.01% | 4086 |
|
|
2022
Q1 | $1.03M | Sell |
905,187
-262,291
| -22% | -$313K | ﹤0.01% | 3858 |
|
|
2021
Q4 | $2.63M | Sell |
1,167,478
-497,763
| -30% | -$1.25M | ﹤0.01% | 3223 |
|
|
2021
Q3 | $5.7M | Buy |
1,665,241
+1,656,811
| +19,654% | +$5.11M | ﹤0.01% | 2719 |
|
|
2021
Q2 | $25K | Sell |
8,430
-552
| -6% | -$1.75K | ﹤0.01% | 5822 |
|
|
2021
Q1 | $29K | Buy |
8,982
+134
| +2% | +$447 | ﹤0.01% | 6051 |
|
|
2020
Q4 | $19K | Buy |
8,848
+57
| +0.6% | +$94 | ﹤0.01% | 5872 |
|
|
2020
Q3 | $10K | Sell |
8,791
-23
| -0.3% | -$24 | ﹤0.01% | 5902 |
|
|
2020
Q2 | $8K | Sell |
8,814
-868
| -9% | -$827 | ﹤0.01% | 5897 |
|
|
2020
Q1 | $8K | Sell |
9,682
-25,119
| -72% | -$29.1K | ﹤0.01% | 5793 |
|
|
2019
Q4 | $33K | Sell |
34,801
-2,900
| -8% | -$3.18K | ﹤0.01% | 5632 |
|
|
2019
Q3 | $39K | Sell |
37,701
-10,760
| -22% | -$14.7K | ﹤0.01% | 5633 |
|
|
2019
Q2 | $87K | Sell |
48,461
-37,138
| -43% | -$59.8K | ﹤0.01% | 5369 |
|
|
2019
Q1 | $161K | Sell |
85,599
-4,602
| -5% | -$6.73K | ﹤0.01% | 4930 |
|
|
2018
Q4 | $107K | Buy |
90,201
+22,735
| +34% | +$40.9K | ﹤0.01% | 5252 |
|
|
2018
Q3 | $183K | Sell |
67,466
-30,323
| -31% | -$62.7K | ﹤0.01% | 5053 |
|
|
2018
Q2 | $187K | Sell |
97,789
-94,704
| -49% | -$191K | ﹤0.01% | 5069 |
|
|
2018
Q1 | $404K | Buy |
192,493
+87,357
| +83% | +$187K | ﹤0.01% | 4549 |
|
|
2017
Q4 | $213K | Buy |
105,136
+91,206
| +655% | +$189K | ﹤0.01% | 4931 |
|
|
2017
Q3 | $19K | Sell |
13,930
-14,966
| -52% | -$18.6K | ﹤0.01% | 5727 |
|
|
2017
Q2 | $45K | Sell |
28,896
-52,597
| -65% | -$101K | ﹤0.01% | 5418 |
|
|
2017
Q1 | $263K | Buy |
81,493
+48,177
| +145% | +$119K | ﹤0.01% | 4643 |
|
|
2016
Q4 | $45K | Sell |
33,316
-8,100
| -20% | -$10.6K | ﹤0.01% | 5400 |
|
|
2016
Q3 | $65K | Sell |
41,416
-3,000
| -7% | -$4.61K | ﹤0.01% | 5163 |
|
|
2016
Q2 | $59K | Sell |
44,416
-2,590
| -6% | -$12.1K | ﹤0.01% | 5132 |
|
|
2016
Q1 | $248K | Sell |
47,006
-8,192
| -15% | -$50.1K | ﹤0.01% | 4277 |
|
|
2015
Q4 | $433K | Sell |
55,198
-34,474
| -38% | -$297K | ﹤0.01% | 4002 |
|
|
2015
Q3 | $757K | Buy |
89,672
+7,889
| +10% | +$72.8K | ﹤0.01% | 3676 |
|
|
2015
Q2 | $895K | Buy |
81,783
+24,031
| +42% | +$308K | ﹤0.01% | 3686 |
|
|
2015
Q1 | $808K | Sell |
57,752
-24,877
| -30% | -$380K | ﹤0.01% | 3664 |
|
|
2014
Q4 | $1.4M | Buy |
82,629
+25,571
| +45% | +$372K | ﹤0.01% | 3283 |
|
|
2014
Q3 | $766K | Sell |
57,058
-2,810
| -5% | -$33.5K | ﹤0.01% | 3645 |
|
|
2014
Q2 | $763K | Buy |
59,868
+8,514
| +17% | +$88.7K | ﹤0.01% | 3688 |
|
|
2014
Q1 | $610K | Buy |
51,354
+15,985
| +45% | +$215K | ﹤0.01% | 3764 |
|
|
2013
Q4 | $489K | Buy |
35,369
+3,624
| +11% | +$51.2K | ﹤0.01% | 3812 |
|
|
2013
Q3 | $553K | Buy |
31,745
+3,634
| +13% | +$69.6K | ﹤0.01% | 3704 |
|
|
2013
Q2 | $455K | Buy |
+28,111
| New | +$870K | ﹤0.01% | 3743 |
|
Other funds holding INFI
Wells Fargo's INFI Position: Q3 2023 in Review
Wells Fargo sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 23,750 shares — an estimated $5K sold.
Wells Fargo first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $5.7M in Q3 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Wells Fargo reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Wells Fargo sold 23,750 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $5K.
- Wells Fargo first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- Wells Fargo's Infinity Pharmaceuticals, Inc. position peaked at $5.7M in Q3 2021.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.